Preoperative Atorvastatin Treatment in CABG Patients Rapidly Improves Vein Graft Redox State by Inhibition of Rac1 and NADPH-Oxidase Activity
Author(s) -
Charalambos Antoniades,
Constantinos Bakogiannis,
Dimitris Tousoulis,
Svetlana Reilly,
Meihua Zhang,
Andreas Paschalis,
Alexios S. Antonopoulos,
Michael Demosthenous,
Antigoni Miliou,
Costas Psarros,
Kyriakoula Marinou,
Nikolaos Sfyras,
George Economopoulos,
Barbara Casadei,
Keith M. Chan,
Christodoulos Stefanadis
Publication year - 2010
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.109.927376
Subject(s) - atorvastatin , medicine , statin , nadph oxidase , pharmacology , endocrinology , gastroenterology , oxidative stress
Statins improve clinical outcome of patients with atherosclerosis, but their perioperative role in patients undergoing coronary artery bypass grafting (CABG) is unclear. We hypothesized that short-term treatment with atorvastatin before CABG would improve the redox state in saphenous vein grafts (SVGs), independently of low-density lipoprotein cholesterol (LDL)-lowering.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom